摘要
髓母细胞瘤(MDB)的预后与肿瘤的分期和风险分级密切相关。根据影像学和腰穿脑脊液细胞学检查可以明确MDB的分期,根据风险分级可以制定个体化的治疗策略,同时预测预后。本文围绕MDB的分期、分型及其研究进展综述如下。
The prognosis of medulloblastoma(MDB)is closely related to the stage and risk grade of the tumor.According to examination of imaging and cerebrospinal fluid cytology,the stage of MDB can be clarified,and individualized treatment strategies can be formulated according to the risk classification,and the prognosis can be predicted.This review summarizes the staging,classification and research progress of MDB as follows.
作者
陈立华
孙恺
陈文锦
夏勇
张洪钿
徐如祥
Chen Lihua;Sun Kai;Chen Wenjin;Xia Yong;Zhang Hongtian;Xu Ruxiang(Department of Neurosurgery,Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital,Chengdu 610072,China)
出处
《中华脑科疾病与康复杂志(电子版)》
2020年第5期293-297,共5页
Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
关键词
髓母细胞瘤
分子分型
肿瘤分期
Medulloblastoma
Molecular typing
Tumor staging